Vasculitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Takayasu arteritis based on the 2022 American College of Rheumatology/EULAR classification criteria
- People who have been receiving a biologic medication (specifically a TNF inhibitor or tocilizumab) for at least 3 years
- People whose disease has been in remission, meaning no signs of active disease based on symptoms, blood tests, and imaging
- People whose treatment has not changed in the past 12 months
- People who have not taken steroid medications (such as prednisone or cortisone) in the past 6 months
- People who are willing and able to sign a written consent form agreeing to take part
Who may not be able to join:
- People who have another active inflammatory condition (such as inflammatory bowel disease or ankylosing spondylitis) that also requires biologic treatment
- People who would be unable to attend the required follow-up appointments after their medication is gradually reduced or stopped
- People who are pregnant or planning to become pregnant during the study period
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Fatma Alibaz-Oner, MD, Marmara University
Phone: 05326368554
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of Patients Maintaining Remission After Biologic Treatment Withdrawal
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.